Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Phenytoin Metabolic Ratio as a Putative Marker of CYP2C9 Activity In-vivo

NCT00162461 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00162461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Phenytoin Metabolic Ratio as a Putative Marker of CYP2C9 Activity In-vivo
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 1998
Completion date
December 31, 2020
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy